市场调查报告书

多重诊断市场(各技术(超高密度、高密度、中密度、低密度、次世代定序分析)、用途、终端用户) - 全球产业分析、规模、构成比、成长率、趋势及预测

Multiplexed Diagnostics Market (Technologies - Very High Density, High Density, Medium Density, Low Density, Next Generation Sequencing Assays; Applications; End Users) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

出版商 Transparency Market Research 商品编码 428064
出版日期 内容资讯 英文 194 Pages
商品交期: 最快1-2个工作天内
价格
多重诊断市场(各技术(超高密度、高密度、中密度、低密度、次世代定序分析)、用途、终端用户) - 全球产业分析、规模、构成比、成长率、趋势及预测 Multiplexed Diagnostics Market (Technologies - Very High Density, High Density, Medium Density, Low Density, Next Generation Sequencing Assays; Applications; End Users) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
出版日期: 2017年01月10日内容资讯: 英文 194 Pages
简介

本报告以多重诊断的全球市场为焦点,提供今后变化的技术、用途、终端用户及地区等各分类的预测,产业结构,推动、阻碍因素,机会,竞争环境等分析资讯和主要加入企业简介汇整。

第1章 序

  • 调查范围和市场区隔
  • 调查亮点

第2章 前提和调查方法

  • 前提
  • 使用的简称
  • 调查方法

第3章 摘要整理

  • 多重诊断的全球市场简述

第4章 市场概要

  • 产品概要
  • 人口动态与市场指标
  • 重要产业活动
  • 多重诊断的全球市场规模(单位:100万美元)预测
  • 多重诊断的全球市场展望
  • 波特的五力分析

第5章 市场动态

  • 推动、阻碍因素的概要分析
  • 推动要素
  • 阻碍因素
  • 机会
  • 机会分析

第6章 多重诊断的全球市场 - 各技术

  • 简介
  • 重要发现
  • 多重诊断的全球市场金额构成比 - 各技术
    • 超高密度多工分析
    • 高密度多工分析
    • 中密度
    • 低密度
    • 次世代定序分析
  • 多重诊断的全球市场向心力分析 - 各技术
  • 重要趋势

第7章 多重诊断的全球市场分析 - 各用途

  • 简介
  • 重要发现
  • 多重诊断的全球市场金额构成比 - 各用途
    • 感染性疾病诊断
    • 肿瘤
    • 自体免疫疾病
    • 心脏疾病
    • 过敏
    • 其他(妊娠、妊娠能力实验等)
  • 多重诊断市场向心力分析 - 各用途
  • 重要趋势

第8章 多重诊断的全球市场分析 - 各终端用户

  • 简介
  • 重要发现
  • 多重诊断的全球市场金额构成比 - 各终端用户
    • 学术研究机关
    • 医院
    • 医药品厂商
    • 临床研究机关
    • 诊断实验室
  • 多重诊断市场向心力分析 - 各终端用户
  • 重要趋势

第9章 多重诊断的全球市场分析 - 各地区

  • 全球市场情形 - 各地区
  • 多重诊断的全球市场金额构成比

第10章 北美的多重诊断市场分析

  • 重要发现
  • 市场概要
  • 北美的多重诊断市场金额构成比分析 - 各国
  • 北美的多重诊断市场金额构成比分析 - 各技术
  • 北美的多重诊断市场金额构成比分析 - 各用途
  • 北美的多重诊断市场金额构成比分析 - 各终端用户
  • 北美的多重诊断市场向心力分析
  • 北美的多重诊断市场趋势

第11章 欧洲的多重诊断市场分析

  • 重要发现
  • 市场概要
  • 欧洲的多重诊断市场金额构成比分析 - 各国
  • 欧洲的多重诊断市场金额构成比分析 - 各技术
  • 欧洲的多重诊断市场金额构成比分析 - 各用途
  • 欧洲的多重诊断市场金额构成比分析 - 各终端用户
  • 欧洲的多重诊断市场向心力分析
  • 欧洲的多重诊断市场趋势

第12章 亚太地区的多重诊断市场分析

  • 重要发现
  • 市场概要
  • 亚太地区的多重诊断市场金额构成比分析 - 各国
  • 亚太地区的多重诊断市场金额构成比分析 - 各技术
  • 亚太地区的多重诊断市场金额构成比分析 - 各用途
  • 亚太地区的多重诊断市场金额构成比分析 - 各终端用户
  • 亚太地区的多重诊断市场向心力分析
  • 亚太地区的多重诊断市场趋势

第13章 中南美的多重诊断市场分析

  • 重要发现
  • 市场概要
  • 中南美的多重诊断市场金额构成比分析 - 各国
  • 中南美的多重诊断市场金额构成比分析 - 各技术
  • 中南美的多重诊断市场金额构成比分析 - 各用途
  • 按中南美的多重诊断市场金额构成比分析 - 终端用户
  • 中南美的多重诊断市场向心力分析
  • 中南美的多重诊断市场趋势

第14章 中东、非洲的多重诊断市场分析

  • 重要发现
  • 市场概要
  • 中东、非洲的多重诊断市场金额构成比分析 - 各国
  • 中东、非洲的多重诊断市场金额构成比分析 - 各技术
  • 中东、非洲的多重诊断市场金额构成比分析 - 各用途
  • 中东、非洲的多重诊断市场金额构成比分析 - 各终端用户
  • 中东、非洲的多重诊断市场向心力分析
  • 中东、非洲的多重诊断市场趋势

第15章 竞争环境

  • 多重诊断的全球市场占有率 - 各企业
  • 竞争矩阵
  • 企业简介(企业详细内容,产业概要,财务,对策概要,SWOT分析)
目录

Global Multiplexed Diagnostics Market: Snapshot

The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations. However, the global multiplexed diagnostics market is being restrained by high costs pertaining to multiplexed diagnostics assay equipment and testing and an overall lack of skilled labor for handling the advanced equipment.

The global multiplexed diagnostics market was valued at US$5.0 bn in 2015. It is projected to reach US$26.36 bn by the end of 2024 after expanding at a CAGR of 20% from 2016 to 2024.

North America's Dominance in Global Multiplexed Diagnostics Market to Continue

The global Multiplexed diagnostics market is segmented on the basis of regions, into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2015, North America bagged for the leading share of the market in terms of value, owing to a rising prevalence of cardiac diseases and cancer in the region. North American players in the multiplexed diagnostics market also benefitted from the greater level of penetration of the national health care services. The region is expected to continue dominating the global multiplexed diagnostics market till 2024, a likelihood attributed to the region's high percentage of the geriatric population, an advanced and structured healthcare industry, and a large scope of application of reimbursement policies from both public and private sources.

In Europe, the market for multiplexed diagnostics is also expected to grow at a substantial rate with the growing involvement of academic and research institutes from Germany and the U.K. North America and Europe are projected to be highly lucrative markets for players from the global multiplexed diagnostics market. Conversely, multiplexed diagnostics have not yet found solid foundations in Latin America, Asia Pacific, and the Middle East & Africa to grow on for now.

image1

Infectious Disease Diagnostics in Full Swing

In terms of applications, the global multiplexed diagnostics market can be divided into autoimmune diseases, oncology, cardiac diseases, infectious disease diagnostic, and allergies. In 2015, a collective lead was attributed to the two segments of infectious disease diagnostics and oncology, due to an increase in the prevalence of infectious diseases along with a growing count of patients suffering from breast cancer, colorectal cancer, and prostate cancer. Oncology, cardiac diseases, and infectious disease diagnostics are expected to be highly beneficial segments for players from the global multiplexed diagnostics market. The segment for cardiac diseases is expected to expand at leading rate over the coming years due to the growing prevalence of various cardiovascular diseases. In terms of end users, the global multiplexed diagnostics market was led by academic research institutes in 2015. It is also expected to be the dominant end user in the market till 2024, owing to an increasing contribution of universities and cancer research centers and the research projects in the field of genetic engineering.

Till 2015, the leading players in the global multiplexed diagnostics market included Agilent Technologies, Bio-Rad Laboratories, Inc., BioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina, Inc., Luminex Corporation, Hologic, Inc., Thermo Fisher Scientific, Inc., Siemens Healthineers, and Abbott Laboratories.

Report Description

Global Multiplexed Diagnostics Market: Overview

This report on the global multiplexed diagnostics market analyzes the current and future scenario of the global market. Rise in private and public funding for genomics and personalized medicine, rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases, and favorable regulatory scenario for new product launch are boosting the growth of the global multiplexed diagnostics market. Multiple Application of multiplexed diagnostics technology, and increasing prevalence of cancer and infectious diseases are some of the factors expected to drive the growth of global multiplexed diagnostics market during the forecast period.

The multiplexed diagnostics market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on technology, application, end-user, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises porter's five forces analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global multiplexed diagnostics market.

Global Multiplexed Diagnostics Market: Scope of the Study

Based on technology type, the market has been segmented into Very high density multiplexed assays, High density multiplexed assays, Medium density multiplexed assays, Low density multiplexed assays, and Next generation sequencing assays. High density multiplexed assays and medium density multiplexed assays are projected to be lucrative segments of the multiplexed diagnostics market, due to increasing demand in academic research institutes and pharmaceutical companies. These segments are expected to grow at a highest CAGR rate during forecast period. The market segments have been analyzed based on cost-effectiveness of the technology, prevalence of the diseases, and growing demand for the diagnostic tools. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on Application type, the Global multiplexed diagnostics market has been segmented into Infectious disease diagnostic, oncology, autoimmune diseases, cardiac diseases, allergies & others which include pregnancy & fertility testing. The market segments have been extensively analyzed based on increase in demand for the disease diagnostic and use in research activities, availability of the technology, and cost efficiency of each technology. Different types of end-users are present in the multiplexed diagnostics market. The end-users are Hospitals, pharmaceutical companies, clinical research organizations, and diagnostic laboratories. Under the end-user segment, the academic research institutes segment accounted for the largest share of the Global multiplexed diagnostics market in 2015 & is expected to dominate the market by 2024.

Global Multiplexed Diagnostics Market: Regional and Competitive Analysis

Geographically, the global Multiplexed Diagnostics Market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, Japan, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, Saudi Arabia, and Rest of Middle East & Africa).

The report also profiles major players in the Global multiplexed diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Agilent Technologies, BioMérieux SA, Bio-Rad Laboratories, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Luminex Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., and Abbott Laboratories.

The global multiplexed diagnostics market has been segmented as given below:

Global Multiplexed Diagnostics Market, by Technology,

  • Very High Density Multiplexed Assays (> 10,000-plex)
  • High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)
  • Medium Density Multiplexed Assays (plex < 500)
  • Low Density Multiplexed Assays (plex ≤ 5)
  • Next Generation Sequencing Assays

Global Multiplexed Diagnostics Market, by Application

  • Infectious Disease Diagnostic
  • Oncology
  • Autoimmune Diseases
  • Cardiac Diseases
  • Allergies
  • Others (pregnancy & fertility testing, etc.)

Global Multiplexed Diagnostics Market, by End User

  • Academic Research Institutes
  • Hospital
  • Pharmaceutical Companies
  • Clinical Research Organizations
  • Diagnostic Laboratories

Global Multiplexed Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Acronyms Used
  • 2.3. Research Methodology

3. Executive Summary

  • 3.1. Global Multiplexed Diagnostics Market Snapshot

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Demographics & Market Indicators
  • 4.3. Key Industry Events
  • 4.4. Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, 2014-2024
  • 4.5. Global Multiplexed Diagnostics Market Outlook
  • 4.6. Porter's Five Forces Analysis

5. Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
    • 5.2.1. Growing demand for automated equipment and multifaceted analytical strategies
    • 5.2.2. Significant private and public funding for genomics and personalized medicine
    • 5.2.3. Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases
    • 5.2.4. Increasing prevalence of cancer and infectious diseases
    • 5.2.5. Favorable regulatory scenario for new product launch
    • 5.2.6. Multiple Application of multiplexed diagnostics technology
  • 5.3. Restraints
    • 5.3.1. High cost associated with multiplexed diagnostics assay
    • 5.3.2. Lack of skilled labor
    • 5.3.3. High cost associated with multiplexed diagnostics assay
    • 5.3.4. Lack of skilled labor
  • 5.4. Opportunities
    • 5.4.1. Focus on extensive R&D to expand existing multiplexed diagnostics applications
    • 5.4.2. Development of generic platforms for multiplexed diagnostics
  • 5.5. Opportunity Analysis

6. Global Multiplexed Diagnostics Market Analysis, by Technology

  • 6.1. Introduction
  • 6.2. Key Findings
  • 6.3. Global Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016-2024
    • 6.3.1. Very High Density Multiplexed Assays (> 10,000-plex)
    • 6.3.2. High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)
    • 6.3.3. Medium Density Multiplexed Assays (plex < 500)
    • 6.3.4. Low Density Multiplexed Assays (plex ≤ 5)
    • 6.3.5. Next Generation Sequencing Assays
  • 6.4. Global Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2014-2024
  • 6.5. Key Trends

7. Global Multiplexed Diagnostics Market Analysis, by Application

  • 7.1. Introduction
  • 7.2. Key Findings
  • 7.3. Global Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 -2024
    • 7.3.1. Infectious Disease Diagnostic
    • 7.3.2. Oncology
    • 7.3.3. Autoimmune Diseases
    • 7.3.4. Cardiac Diseases
    • 7.3.5. Allergies
    • 7.3.6. Others (pregnancy & fertility testing, etc.)
  • 7.4. Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2014-2024
  • 7.5. Key Trends

8. Global Multiplexed Diagnostics Market Analysis, by End User

  • 8.1. Introduction
  • 8.2. Key Findings
  • 8.3. Global Multiplexed Diagnostics Market Value Share Analysis, by End-user 2016-2024
    • 8.3.1. Academic Research Institutes
    • 8.3.2. Hospitals
    • 8.3.3. Pharmaceutical Companies
    • 8.3.4. Clinical Research Organizations
    • 8.3.5. Diagnostic Laboratories
  • 8.4. Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • 8.5. Key Trends

9. Global Multiplexed Diagnostics Market Analysis, by Region

  • 9.1. Global Market Scenario by Country
  • 9.2. Global Multiplexed Diagnostics Market Value Share Analysis, by Region, 2016 and 2024

10. North America Multiplexed Diagnostics Market Analysis

  • 10.1. Key Findings
  • 10.2. Market Overview
  • 10.3. North America Multiplexed Diagnostics Market Value Share Analysis, by Country
  • 10.4. North America Multiplexed Diagnostics Market Value Share Analysis, by Technology
  • 10.5. North America Multiplexed Diagnostics Market Value Share Analysis, by Application
  • 10.6. North America Multiplexed Diagnostics Market Value Share Analysis, by End User
  • 10.7. North America Multiplexed Diagnostics Market Attractiveness Analysis
  • 10.8. North America Multiplexed Diagnostics Market Trends

11. Europe Multiplexed Diagnostics Market Analysis

  • 11.1. Key Findings
  • 11.2. Market Overview
  • 11.3. Europe Multiplexed Diagnostics Market Value Share Analysis, by Country
  • 11.4. Europe Multiplexed Diagnostics Market Value Share Analysis, by Technology
  • 11.5. Europe Multiplexed Diagnostics Market Value Share Analysis, by Application
  • 11.6. Europe Multiplexed Diagnostics Market Value Share Analysis, by End User
  • 11.7. Europe Multiplexed Diagnostics Market Attractiveness Analysis
  • 11.8. Europe Multiplexed Diagnostics Market Trends

12. Asia Pacific Multiplexed Diagnostics Market Analysis

  • 12.1. Key Findings
  • 12.2. Market Overview
  • 12.3. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Country
  • 12.4. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Technology
  • 12.5. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Application
  • 12.6. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by End User
  • 12.7. Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis
  • 12.8. Asia Pacific Multiplexed Diagnostics Market Trends

13. Latin America Multiplexed Diagnostics Market Analysis

  • 13.1. Key Findings
  • 13.2. Market Overview
  • 13.3. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Country
  • 13.4. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Technology
  • 13.5. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Application
  • 13.6. Latin America Multiplexed Diagnostics Market Value Share Analysis, by End User
  • 13.7. Latin America Multiplexed Diagnostics Market Attractiveness Analysis
  • 13.8. Latin America Multiplexed Diagnostics Market Trends

14. Middle East & Africa Multiplexed Diagnostics Market Analysis

  • 14.1. Key Findings
  • 14.2. Market Overview
  • 14.3. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Country
  • 14.4. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Technology
  • 14.5. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Application
  • 14.6. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by End User
  • 14.7. Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis
  • 14.8. Middle East & Africa Multiplexed Diagnostics Market Trends

15. Competition Landscape

  • 15.1. Multiplexed Diagnostics Market Share Analysis By Company, 2015
  • 15.2. Competition Matrix
  • 15.3. Company Profiles
    • 15.3.1. Agilent Technologies
      • 15.3.1.1. Company Details
      • 15.3.1.2. Business Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. Strategic Overview
      • 15.3.1.5. SWOT Analysis
    • 15.3.2. bioMérieux SA
      • 15.3.2.1. Company Details
      • 15.3.2.2. Business Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. Strategic Overview
      • 15.3.2.5. SWOT Analysis
    • 15.3.3. Bio-Rad Laboratories, Inc.
      • 15.3.3.1. Company Details
      • 15.3.3.2. Business Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. Strategic Overview
      • 15.3.3.5. SWOT Analysis
    • 15.3.4. Illumina, Inc.
      • 15.3.4.1. Company Details
      • 15.3.4.2. Business Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. Strategic Overview
      • 15.3.4.5. SWOT Analysis
    • 15.3.5. F. Hoffmann-La Roche Ltd.
      • 15.3.5.1. Company Details
      • 15.3.5.2. Business Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. Strategic Overview
      • 15.3.5.5. SWOT Analysis
    • 15.3.6. Hologic, Inc.
      • 15.3.6.1. Company Details
      • 15.3.6.2. Business Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. Strategic Overview
      • 15.3.6.5. SWOT Analysis
    • 15.3.7. Luminex Corporation
      • 15.3.7.1. Company Details
      • 15.3.7.2. Business Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. Strategic Overview
      • 15.3.7.5. SWOT Analysis
    • 15.3.8. Siemens Healthineers
      • 15.3.8.1. Company Details
      • 15.3.8.2. Business Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. Strategic Overview
      • 15.3.8.5. SWOT Analysis
    • 15.3.9. Thermo Fisher Scientific, Inc.
      • 15.3.9.1. Company Details
      • 15.3.9.2. Business Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. Strategic Overview
      • 15.3.9.5. SWOT Analysis
    • 15.3.10. Abbott Laboratories
      • 15.3.10.1. Company Details
      • 15.3.10.2. Business Overview
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. Strategic Overview
      • 15.3.10.5. SWOT Analysis

List of Figures

  • FIG. 1 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, 2014-2024
  • FIG. 2 Multiplexed Diagnostics Market Value Share, by Application (2016)
  • FIG. 3 Multiplexed Diagnostics Market Value Share, by Region (2016)
  • FIG. 4 Multiplexed Diagnostics Market Value Share, by Technology (2016)
  • FIG. 5 Multiplexed Diagnostics Market Value Share, by End-user (2016)
  • FIG. 6 Global Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 7 Global Very High Density Multiplexed Assays (> 10,000-plex) Market Revenue (US$ Mn), 2014-2024
  • FIG. 8 Global High Density Multiplexed Assays (500 ≤ plex ≤ 10,000) Market Revenue (US$ Mn), 2014-2024
  • FIG. 9 Global Medium Density Multiplexed Assays (plex < 500) Market Revenue (US$ Mn), 2014-2024
  • FIG. 10 Global Low Density Multiplexed Assays (plex ≤ 5) Market Revenue (US$ Mn), 2014-2024
  • FIG. 11 Global Next Generation Sequencing Assays Market Revenue (US$ Mn), 2014-2024
  • FIG. 12 Multiplexed Diagnostics Market Attractiveness Analysis, by Technology , 2016-2024
  • FIG. 13 Global Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 14 Global Infectious Disease Diagnostic Market Revenue (US$ Mn), 2014-2024
  • FIG. 15 Global Oncology Market Revenue (US$ Mn), 2014-2024
  • FIG. 16 Global Infectious Disease Diagnostic Market Revenue (US$ Mn), 2014-2024
  • FIG. 17 Global Cardiac Diseases Market Revenue (US$ Mn), 2014-2024
  • FIG. 18 Global Allergies Market Revenue (US$ Mn), 2014-2024
  • FIG. 19 Global Others Market Revenue (US$ Mn), 2014-2024
  • FIG. 20 Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2014-2024
  • FIG. 21 Global Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
  • FIG. 22 Global Academic Research Institutes Market Revenue (US$ Mn), 2014-2024
  • FIG. 23 Global Hospitals Market Revenue (US$ Mn), 2014-2024
  • FIG. 24 Global Pharmaceutical Companies Market Revenue (US$ Mn), 2014-2024
  • FIG. 25 Global Clinical Research Organizations Market Revenue (US$ Mn), 2014-2024
  • FIG. 26 Global Diagnostic Laboratories Market Revenue (US$ Mn), 2014-2024
  • FIG. 27 Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 28 Global Multiplexed Diagnostics Market Value Share Analysis, by Region, 2016 and 2024
  • FIG. 29 Global Multiplexed Diagnostics Market Attractiveness Analysis, by Region, 2014-2024
  • FIG. 30 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014-2024
  • FIG. 31 North America Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016-2024
  • FIG. 32 North America Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
  • FIG. 33 North America Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 34 North America Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 35 North America Multiplexed Diagnostics Market Value Share Analysis, by End User, 2016 and 2024
  • FIG. 36 North America Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016-2024
  • FIG. 37 North America Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016-2024
  • FIG. 38 North America Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 39 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014-2024
  • FIG. 40 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016-2024
  • FIG. 41 Europe Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
  • FIG. 42 Europe Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 43 Europe Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 44 Europe Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
  • FIG. 45 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016-2024
  • FIG. 46 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016-2024
  • FIG. 47 Europe Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 48 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014-2024
  • FIG. 49 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016-2024
  • FIG. 50 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
  • FIG. 51 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 52 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 53 Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
  • FIG. 54 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016-2024
  • FIG. 55 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016-2024
  • FIG. 56 Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 57 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014-2024
  • FIG. 58 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016-2024
  • FIG. 59 Latin America Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
  • FIG. 60 Latin America Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 61 Latin America Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 62 Latin America Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
  • FIG. 63 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016-2024
  • FIG. 64 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016-2024
  • FIG. 65 Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 66 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014-2024
  • FIG. 67 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2016-2024
  • FIG. 68 Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Country, 2016 and 2024
  • FIG. 69 Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
  • FIG. 70 Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Application, 2016 and 2024
  • FIG. 71 Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
  • FIG. 72 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2016-2024
  • FIG. 73 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2016-2024
  • FIG. 74 Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024
  • FIG. 75 Global Multiplexed Diagnostics Market Share Analysis, by Company, 2016 (Estimated)

List of Tables

  • TABLE 1 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 2 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 3 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
  • TABLE 4 Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Region, 2014-2024
  • TABLE 5 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • TABLE 6 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 7 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 8 North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
  • TABLE 9 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • TABLE 10 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 11 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 12 Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
  • TABLE 13 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • TABLE 14 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 15 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 16 Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
  • TABLE 17 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • TABLE 18 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 19 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 20 Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024
  • TABLE 21 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • TABLE 22 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2014-2024
  • TABLE 23 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • TABLE 24 Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2014-2024